Christopher Turner

1.5k total citations
14 papers, 1.1k citations indexed

About

Christopher Turner is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Christopher Turner has authored 14 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Oncology. Recurrent topics in Christopher Turner's work include Biodiesel Production and Applications (2 papers), Glioma Diagnosis and Treatment (2 papers) and Chromatin Remodeling and Cancer (2 papers). Christopher Turner is often cited by papers focused on Biodiesel Production and Applications (2 papers), Glioma Diagnosis and Treatment (2 papers) and Chromatin Remodeling and Cancer (2 papers). Christopher Turner collaborates with scholars based in United States, Australia and United Kingdom. Christopher Turner's co-authors include Lars K. Nielsen, Jens O. Krömer, Mary Ann Zimmerman, Mark W. Kieran, Susan Chi, Liliana Goumnerova, Karen J. Marcus, Daniel Klein‐Marcuschamer, Christine Chordas and Anthony H.V. Schapira and has published in prestigious journals such as Journal of Clinical Oncology, Water Research and Cancer.

In The Last Decade

Christopher Turner

14 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher Turner United States	12	651	218	160	157	152	14	1.1k
Dingyang Liu China	15	297 0.5×	201 0.9×	113 0.7×	50 0.3×	62 0.4×	63	885
Natalia Rozwadowska Poland	21	780 1.2×	50 0.2×	327 2.0×	25 0.2×	145 1.0×	78	1.5k
Xiaolin Wang China	20	539 0.8×	164 0.8×	216 1.4×	89 0.6×	70 0.5×	106	1.5k
José Tomás Egaña Chile	26	515 0.8×	31 0.1×	238 1.5×	48 0.3×	500 3.3×	58	1.6k
J. Jasmin Brazil	16	247 0.4×	64 0.3×	182 1.1×	23 0.1×	119 0.8×	37	881
Yansong Wang China	23	475 0.7×	182 0.8×	55 0.3×	25 0.2×	156 1.0×	75	1.2k
Milena Králíčková Czechia	24	387 0.6×	50 0.2×	55 0.3×	35 0.2×	176 1.2×	103	1.9k
Fei Xie China	17	246 0.4×	50 0.2×	94 0.6×	105 0.7×	42 0.3×	64	779
Yuliang Feng China	17	1.1k 1.6×	70 0.3×	111 0.7×	10 0.1×	45 0.3×	47	1.5k
Mingxin Zhu China	18	204 0.3×	38 0.2×	207 1.3×	80 0.5×	82 0.5×	50	713

Countries citing papers authored by Christopher Turner

Since Specialization

Citations

This map shows the geographic impact of Christopher Turner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Turner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Turner more than expected).

Fields of papers citing papers by Christopher Turner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Turner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Turner. The network helps show where Christopher Turner may publish in the future.

Co-authorship network of co-authors of Christopher Turner

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Turner. A scholar is included among the top collaborators of Christopher Turner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Turner. Christopher Turner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Turner, Christopher, et al.. (2019). Silica fouling during groundwater RO treatment: The effect of colloids’ radius of curvature on dissolution and polymerisation. Water Research. 168. 115135–115135. 11 indexed citations

Ott, Patrick A., Anna C. Pavlick, Douglas B. Johnson, et al.. (2019). A phase 2 study of glembatumumab vedotin, an antibody‐drug conjugate targeting glycoprotein NMB, in patients with advanced melanoma. Cancer. 125(7). 1113–1123. 51 indexed citations

Niclis, Jonathan C., Christopher Turner, Jennifer C. Durnall, et al.. (2017). Long-Distance Axonal Growth and Protracted Functional Maturation of Neurons Derived from Human Induced Pluripotent Stem Cells After Intracerebral Transplantation. Stem Cells Translational Medicine. 6(6). 1547–1556. 19 indexed citations

Cox, Kelly, et al.. (2014). Environmental life cycle assessment ( LCA ) of aviation biofuel from microalgae, Pongamia pinnata , and sugarcane molasses. Biofuels Bioproducts and Biorefining. 8(4). 579–593. 51 indexed citations

Gore, Lia, Tanya Trippett, Howard M. Katzenstein, et al.. (2013). A Multicenter, First-in-Pediatrics, Phase 1, Pharmacokinetic and Pharmacodynamic Study of Ridaforolimus in Patients with Refractory Solid Tumors. Clinical Cancer Research. 19(13). 3649–3658. 19 indexed citations

Klein‐Marcuschamer, Daniel, Christopher Turner, M. Allen, et al.. (2013). Technoeconomic analysis of renewable aviation fuel from microalgae, Pongamia pinnata, and sugarcane. Biofuels Bioproducts and Biorefining. 7(4). 416–428. 106 indexed citations

Adam, Robert, Alexander Leff, Christopher Turner, et al.. (2012). Dopamine reverses reward insensitivity in apathy following globus pallidus lesions. Cortex. 49(5). 1292–1303. 86 indexed citations

Turner, Christopher, et al.. (2012). Alleviating monoterpene toxicity using a two‐phase extractive fermentation for the bioproduction of jet fuel mixtures in Saccharomyces cerevisiae. Biotechnology and Bioengineering. 109(10). 2513–2522. 156 indexed citations

Reardon, David A., Patrick Y. Wen, W. K. Alfred Yung, et al.. (2011). Ridaforolimus for patients with progressive or recurrent malignant glioma: a perisurgical, sequential, ascending-dose trial. Cancer Chemotherapy and Pharmacology. 69(4). 849–860. 15 indexed citations

10.

Chi, Susan, Mary Ann Zimmerman, Xiaopan Yao, et al.. (2008). Intensive Multimodality Treatment for Children With Newly Diagnosed CNS Atypical Teratoid Rhabdoid Tumor. Journal of Clinical Oncology. 27(3). 385–389. 297 indexed citations

11.

Kieran, Mark W., Christopher Turner, Joshua B. Rubin, et al.. (2005). A Feasibility Trial of Antiangiogenic (Metronomic) Chemotherapy in Pediatric Patients With Recurrent or Progressive Cancer. Journal of Pediatric Hematology/Oncology. 27(11). 573–581. 155 indexed citations

12.

Zimmerman, Mary Ann, Liliana Goumnerova, Mark R. Proctor, et al.. (2005). Continuous remission of newly diagnosed and relapsed central nervous system atypical teratoid/rhabdoid tumor. Journal of Neuro-Oncology. 72(1). 77–84. 57 indexed citations

13.

Turner, Christopher, Sridharan Gururangan, J.W. Eastwood, et al.. (2002). Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: The Duke experience. Neuro-Oncology. 4(2). 102–108. 2 indexed citations

14.

Turner, Christopher & Anthony H.V. Schapira. (2001). Mitochondrial Dysfunction in Neurodegenerative Disorders and Ageing. Advances in experimental medicine and biology. 487. 229–251. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact